EX-2.1
from 8-K
103 pages
Certain Confidential Information Contained in This Document, Marked by [***], Has Been Omitted Because It Is Both (I) Not Material and (II) Is the Type That the Registrant Treats as Private or Confidential. Agreement and Plan of Merger by and Among Blueprint Medicines Corporation, Pavonis Merger Subsidiary, Inc., Lengo Therapeutics, Inc., and Fortis Advisors LLC, as the Stockholders’ Representative (For the Limited Purposes Described Herein) November 27, 2021
12/34/56
